Pharmacokinetic and pharmacodynamic properties of canakinumab in patients with gouty arthritis-Reference-Cited by-同舟云学术

Pharmacokinetic and pharmacodynamic properties of canakinumab in patients with gouty arthritis

Author:

Chakraborty Abhijit¹,Van Linh M.²,Skerjanec Andrej³,Floch David³,Klein Ulf R.³,Krammer Gerhard⁴,Sunkara Gangadhar⁵,Howard Dan¹

Affiliation:

1. Clinical Pharmacology; Novartis Pharmaceuticals Corporation; East Hanover NJ USA

2. Advanced Quantitative Sciences; Novartis Institute for Biomedical Research; Cambridge MA USA

3. Biologics & Safety Disposition; Novartis Institute for Biomedical Research; Basel Switzerland

4. Clinical Development Unit, Department of Integrated Hospital Care Franchise; Novartis Pharma AG; Basel Switzerland

5. Clinical PK/PD, Drug Metabolism and Pharmacokinetics; Novartis Institutes for Biomedical Research; East Hanover NJ USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference17 articles.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Newer Therapies in Rheumatology;Medical Clinics of North America;2024-09

3. Interleukin-1 in Coronary Artery Disease;Current Topics in Medicinal Chemistry;2022-11